Skip to content
  • Saturday, 22 August 2026
  • 12:51 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Immunai’s Digital ‘Plumbing’ Keeps AstraZeneca Coming Back
Laboratory Automation & Robotics

Immunai’s Digital ‘Plumbing’ Keeps AstraZeneca Coming Back

Lana Keisha Jul 3, 2026 0

Immunai, a pioneering startup dedicated to constructing a comprehensive foundation model of the human immune system, has significantly deepened its…

Read More
Laboratory Automation & Robotics

Immunai’s digital ‘plumbing’ keeps AstraZeneca coming back

Lana Keisha Jun 26, 2026 0

Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has announced a significant expansion…

Read More
Laboratory Automation & Robotics

Immunai’s digital ‘plumbing’ keeps AstraZeneca coming back

Lana Keisha Jun 17, 2026 0

Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has significantly expanded its oncology…

Read More
Laboratory Automation & Robotics

Immunai’s Digital "Plumbing" Secures Third Expansion with AstraZeneca, Deepening AI Integration Across Clinical Pipeline

Lana Keisha May 29, 2026 0

Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has announced its third significant…

Read More
Laboratory Automation & Robotics

Immunai’s Digital ‘Plumbing’ Keeps AstraZeneca Coming Back for Broader, Deeper Collaborations

Lana Keisha May 22, 2026 0

Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has significantly expanded its strategic…

Read More
Can live cell dynamics fix drug discovery’s efficacy problem?Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnelsAviadoBio Expands Exclusive Licensing of vMiX Gene-Silencing Platform to Encompass All Human Therapeutic AreasResearchers at Osaka University Identify Critical Protein Interaction Regulating Sperm Morphology and Male Fertility
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ